Berberine attenuates septic cardiomyopathy by inhibiting TLR4/NF-κB signalling in rats
Context Berberine (Ber) can increase the survival rate of septic mice and inhibit inflammation, but whether it has a protective effect on septic cardiomyopathy (SCM) is unclear. Objective To investigate whether Ber ameliorates SCM in a rat model and its potential mechanism. Materials and methods Mal...
Main Authors: | Huiqi Chen, Qian Liu, Xiangqi Liu, Jinlan Jin |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2021-01-01
|
Series: | Pharmaceutical Biology |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/13880209.2021.1877736 |
Similar Items
-
Septic Cardiomyopathy
by: Ivana Lukić, et al.
Published: (2024-01-01) -
Diagnostics of septic myocardial dysfunction in neonates
by: O.K. Koloskova, et al.
Published: (2022-09-01) -
Comparative transcriptome analysis of transcripts of uncertain coding potential in septic myocardial depression
by: Tie-Ning Zhang, et al.
Published: (2021-04-01) -
Progress in the mechanism of mitochondrial dysfunction in septic cardiomyopathy
by: Leijing Yin, et al.
Published: (2022-12-01) -
Prognostic impact of isolated right ventricular dysfunction in sepsis and septic shock: an 8-year historical cohort study
by: Saraschandra Vallabhajosyula, et al.
Published: (2017-09-01)